Viracor Eurofins' Algorithms Predict Risk of aGVHD and Non-relapse Mortality in Allogeneic HCT Patients

LEE'S SUMMIT, Mo., Aug. 8, 2018 /PRNewswire/ -- Viracor Eurofins today announced the launch of the first commercially available predictive acute Graft versus Host Disease (aGVHD) algorithms to help identify at-risk patients. Acute GVHD is a major complication following allogeneic...